{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:33:13Z","timestamp":1789601593502,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":245,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100994","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:25:21Z","timestamp":1757093121000},"page":"100994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advances in targeted prostate cancer diagnosis and therapy using ultrasound imaging combined with novel nanocarriers:facilitating early detection and effective treatment of prostate cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"Hannian","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-5856","authenticated-orcid":false,"given":"Mingqiu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctarc.2025.100994_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100994_bib0002","first-page":"98","article-title":"Advances in epidemiology of prostate cancer in China[J]","volume":"48","author":"LI","year":"2021","journal-title":"Cancer Res. Prevent. Treatment"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100994_bib0003","first-page":"123","article-title":"Normal weight, overweight and obesity conditions associated to prostate neoplasm stages: a systematic review and meta-analysis","volume":"13","author":"Vitale","year":"2025","journal-title":"Biomedicines."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100994_bib0004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17425255.2022.2072727","article-title":"Incidence of grade 3\u20134 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis","volume":"18","author":"Rizzo","year":"2022","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"issue":"Pt 3","key":"10.1016\/j.ctarc.2025.100994_bib0005","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.semcancer.2021.09.007","article-title":"Microbiota and prostate cancer","volume":"86","author":"Rizzo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ctarc.2025.100994_bib0006","article-title":"Prognostic significance of the cachexia index (CXI) in patients with cancer: a systematic review and meta-analysis","volume":"56","author":"Bas","year":"2025","journal-title":"Clin. Nutr. ESPEN."},{"key":"10.1016\/j.ctarc.2025.100994_bib0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2025.100994_bib0008","first-page":"10","article-title":"Nanoparticle-based drug delivery systems for cancer therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart. Mater. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100994_bib0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajco.13521","article-title":"Low-frequency ultrasound combined with microbubbles improves gene transfection in prostate cancer cells in vitro and in vivo","volume":"18","author":"Zhang","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100994_bib0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3892\/ol.2016.4703","article-title":"Low-frequency ultrasound-mediated microvessel disruption combined with docetaxel to treat prostate carcinoma xenografts in nude mice: a novel type of chemoembolization","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ctarc.2025.100994_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100184","article-title":"Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy","volume":"14","author":"Fang","year":"2023","journal-title":"OpenNano"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100994_bib0012","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14366\/usg.17021","article-title":"Ultrasound-guided drug delivery in cancer","volume":"36","author":"Mullick Chowdhury","year":"2017","journal-title":"Ultrasonography."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100994_bib0013","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100994_bib0014","first-page":"1597","article-title":"Research and application progress of drug-loaded liposomes","volume":"10","author":"Yang","year":"2007","journal-title":"J. Mater. Sci. Eng."},{"key":"10.1016\/j.ctarc.2025.100994_bib0015","article-title":"Low-frequency ultrasound combined with microbubbles improves gene transfection in prostate cancer cells in vitro and in vivo","author":"Zhang","year":"2021","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100994_bib0016","first-page":"298","article-title":"Research progress on the application of ultrasound molecular targeted contrast agents","volume":"45","author":"Yang","year":"2023","journal-title":"Acta Academiae Medicinae Sinicae"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100994_bib0017","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.bioconjchem.6b00222","article-title":"Design of a small-molecule drug conjugate for prostate cancer targeted theranostics[J]","volume":"27","author":"Kumar","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100994_bib0018","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/s41598-021-84072-5","article-title":"Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2025.100994_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clgc.2015.03.006","article-title":"Hypoxia and prostate cancer aggressiveness: a tale with many endings","volume":"13","author":"Fraga","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2025.100994_bib0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1039\/C8NH00340H","article-title":"Ultrasound activation of liposomes for enhanced ultrasound imaging and synergistic gas and sonodynamic cancer therapy","volume":"4","author":"Lin","year":"2019","journal-title":"Nanoscale Horiz."},{"issue":"12","key":"10.1016\/j.ctarc.2025.100994_bib0021","first-page":"1190","article-title":"In vivo biodistribution and toxicity evaluation of polymeric and lipid-based nanoparticles: a potential approach for chronic diseases treatment","volume":"12","author":"Costa","year":"2020","journal-title":"Pharmaceutics."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100994_bib0022","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1080\/03639045.2018.1483383","article-title":"The characterization, pharmacokinetic, and tissue distribution studies of TPGS-modified artesunate liposome in rats","volume":"44","author":"Wang","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ctarc.2025.100994_bib0023","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2022.11.021","article-title":"Ultrasound nanotheranostics: toward precision medicine","volume":"353","author":"Qin","year":"2023","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100994_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","article-title":"Mesoporous silica nanoparticles in drug delivery and biomedical applications","volume":"11","author":"Wang","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ctarc.2025.100994_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/2230-973X.160844","article-title":"Mesoporous silica nanoparticles in target drug delivery system: a review","volume":"5","author":"Bharti","year":"2015","journal-title":"Int. J. Pharma. Investig."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100994_bib0026","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/asia.201301333","article-title":"Effective cancer cell killing by hydrophobic nanovoid-enhanced cavitation under safe low-energy ultrasound","volume":"9","author":"Zhao","year":"2014","journal-title":"Chem. Asian J."},{"issue":"11","key":"10.1016\/j.ctarc.2025.100994_bib0027","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1021\/acsnano.5b04378","article-title":"Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers","volume":"9","author":"Paris","year":"2015","journal-title":"ACS. Nano"},{"issue":"19","key":"10.1016\/j.ctarc.2025.100994_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000877","article-title":"Cavitation-inducible mesoporous silica-titania nanoparticles for cancer sonotheranostics","volume":"9","author":"Lee","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"23","key":"10.1016\/j.ctarc.2025.100994_bib0029","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1002\/adma.201205292","article-title":"In vivo bio-safety evaluations and diagnostic\/therapeutic applications of chemically designed mesoporous silica nanoparticles","volume":"25","author":"Chen","year":"2013","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100994_bib0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/smll.201001459","article-title":"In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation","volume":"7","author":"He","year":"2011","journal-title":"Small."},{"key":"10.1016\/j.ctarc.2025.100994_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201604634","article-title":"Degradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticles","volume":"29","author":"Croissant","year":"2017","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.ctarc.2025.100994_bib0032","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/pharmaceutics16101332","article-title":"Review of gold nanoparticles: synthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy","volume":"16","author":"Georgiou","year":"2024","journal-title":"Pharmaceutics."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100994_bib0033","doi-asserted-by":"crossref","first-page":"467","DOI":"10.17344\/acsi.2023.8216","article-title":"Rise of gold nanoparticles as carriers of therapeutic agents","volume":"70","author":"Pattnaik","year":"2023","journal-title":"Acta Chim. Slov."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100994_bib0034","doi-asserted-by":"crossref","first-page":"570","DOI":"10.12677\/OJNS.2023.114068","article-title":"Study on sonodynamic damage proteins of gold nanoparticles","volume":"11","author":"Li","year":"2023","journal-title":"Open J. Natural Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100994_bib0035","first-page":"838","article-title":"Study on gold nanoparticle-microbubble composite materials and their in vitro imaging and photothermal properties","author":"Yue","year":"2021","journal-title":"J. Nanjing Med. Univ. (Natural Science Edition)"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100994_bib0036","first-page":"14","article-title":"Dynamics of cavitation bubbles on the surface of gold nanoparticles under the combined irradiations of laser and ultrasound","volume":"35","author":"Xu","year":"2010","journal-title":"Acta Acustica"},{"key":"10.1016\/j.ctarc.2025.100994_bib0037","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2018.04.005","article-title":"The systematic evaluation of size-dependent toxicity and multi-time biodistribution of gold nanoparticles","volume":"167","author":"Li","year":"2018","journal-title":"Colloids. Surf. B Biointerfaces."},{"issue":"14","key":"10.1016\/j.ctarc.2025.100994_bib0038","first-page":"7676","article-title":"Pharmacokinetics, biodistribution and biosafety of PEGylated gold nanoparticles in vivo","volume":"22","author":"Kopeck\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ctarc.2025.100994_bib0039","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Molecules."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100994_bib0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/polym16020249","article-title":"Polymeric nanoparticles for biomedical applications","volume":"16","author":"Andrade","year":"2024","journal-title":"Polymers"},{"issue":"21","key":"10.1016\/j.ctarc.2025.100994_bib0041","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aaff96","article-title":"Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells","volume":"30","author":"Bessone","year":"2019","journal-title":"Nanotechnology."},{"issue":"11","key":"10.1016\/j.ctarc.2025.100994_bib0042","doi-asserted-by":"crossref","first-page":"12899","DOI":"10.1021\/acsami.1c00077","article-title":"Dual pH- and glutathione-responsive CO2-generating nanodrug delivery system for contrast-enhanced ultrasonography and therapy of prostate cancer","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl. Mater. Interfaces (Providence)"},{"key":"10.1016\/j.ctarc.2025.100994_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1141984","article-title":"Laser-activated nanoparticles for ultrasound\/photoacoustic imaging-guided prostate cancer treatment","volume":"11","author":"Xiao","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1\u20133","key":"10.1016\/j.ctarc.2025.100994_bib0044","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","article-title":"Design of biodegradable particles for protein delivery","volume":"78","author":"Vila","year":"2002","journal-title":"J. Control Release"},{"key":"10.1016\/j.ctarc.2025.100994_bib0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.colsurfb.2012.06.024","article-title":"Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats","volume":"101","author":"Khalil","year":"2013","journal-title":"Colloids. Surf. B Biointerfaces."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100994_bib0046","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2006.11.025","article-title":"Non-ionic amphiphilic biodegradable PEG-PLGA-PEG copolymer enhances gene delivery efficiency in rat skeletal muscle","volume":"118","author":"Chang","year":"2007","journal-title":"J. Control Release"},{"issue":"9","key":"10.1016\/j.ctarc.2025.100994_bib0047","first-page":"9","article-title":"Preparation, characterization and in vitro release of crebanine-loaded PLGA nanoparticles","volume":"24","author":"Cheng","year":"2018","journal-title":"Chin. J. Exp. Tradit. Med. Form"},{"key":"10.1016\/j.ctarc.2025.100994_bib0048","series-title":"Ultrasound-responsive Microbubbles and nanodroplets: A pathway to Targeted Drug Delivery","author":"Shakya","year":"2024"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100994_bib0049","first-page":"381","article-title":"Targeting of microbubbles: contrast agents for ultrasound molecular imaging","volume":"36","author":"Klibanov","year":"2010","journal-title":"Ultrasound. Med. Biol."},{"issue":"15","key":"10.1016\/j.ctarc.2025.100994_bib0050","first-page":"5373","article-title":"BR55 ultrasound molecular imaging of orthotopic prostate cancer in a patient-derived xenograft model","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics."},{"issue":"29","key":"10.1016\/j.ctarc.2025.100994_bib0051","first-page":"47664","article-title":"Nilotinib enhances tumor angiogenesis by down-regulating the soluble form of VEGFR-1 in breast cancer xenograft models","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100994_bib0052","first-page":"5629","article-title":"Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantitative ultrasound molecular imaging in prostate cancer","volume":"49","author":"Wang","year":"2022","journal-title":"Med. Phys."},{"issue":"12","key":"10.1016\/j.ctarc.2025.100994_bib0053","first-page":"6681","article-title":"Quantification of extravasation and binding of PSMA-targeted nanobubbles in prostate cancer using dynamic contrast-enhanced ultrasound","volume":"29","author":"Wang","year":"2019","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100994_bib0054","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-8722-5-39","article-title":"Nanotechnology for the diagnosis and treatment of malignant tumors: recent advances and future perspectives","volume":"16","author":"Chen","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2025.100994_bib0055","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/s41598-021-84072-5","article-title":"Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2025.100994_bib0056","article-title":"Advances in the research on the properties and applications of micro-nano bubbles","volume":"313","author":"Duncanson","year":"2023","journal-title":"Adv. Colloid. Interface Sci."},{"key":"10.1016\/j.ctarc.2025.100994_bib0057","first-page":"1371","article-title":"Nano-structures as drug delivery systems for cancer therapy: classification, preclinical and clinical studies","volume":"13","author":"Akbarzadeh","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ctarc.2025.100994_bib0058","series-title":"Transformative Journeys: Harnessing AI and Innovation for Sustainable Development of the Pharmaceutical and Healthcare Sector","first-page":"123","author":"Parashar","year":"2024"},{"key":"10.1016\/j.ctarc.2025.100994_bib0059","article-title":"Surface chemical modification of gold nanoparticles: a tool for improving biocompatibility and cellular internalization","volume":"319","author":"Fratoddi","year":"2023","journal-title":"Adv. Colloid. Interface Sci."},{"issue":"44","key":"10.1016\/j.ctarc.2025.100994_bib0060","first-page":"9127","article-title":"Gold nanoparticles in targeted prostate cancer therapy: recent advances and future perspectives","volume":"10","author":"Singh","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ctarc.2025.100994_bib0061","doi-asserted-by":"crossref","first-page":"128ra39","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100994_bib0062","first-page":"1841","article-title":"Multifunctional mesoporous silica nanoparticles for cancer therapy: current status and future prospects","volume":"17","author":"Liong","year":"2023","journal-title":"ACS. Nano"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:34:28Z","timestamp":1765485268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":62,"alternative-id":["S2468294225001303"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100994","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in targeted prostate cancer diagnosis and therapy using ultrasound imaging combined with novel nanocarriers:facilitating early detection and effective treatment of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100994"}}